Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5435336 | 0.78 | CA1 (0.34) | CA1CA2ALOX15EPHX1LMNA | |
| SCHEMBL9022618 | 0.75 | CA2 (0.43) | CA1CA2ALOX15EPHX1 | |
| SCHEMBL11373046 | 0.72 | — | — | |
| SCHEMBL31396679 | 0.70 | CA1 (0.39) | CA1CA2EPHX1 | |
| SCHEMBL28309381 | 0.69 | CA1 (0.33) | CA1CA2EPHX1 | |
| SCHEMBL222605 | 0.67 | LMNA (0.35) | ALOX15LMNABLMPMP22 | |
| SCHEMBL9328869 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL3586576 | 0.65 | LMNA (0.33) | ALOX15LMNABLMPMP22 | |
| SCHEMBL7890644 | 0.61 | FDPS (0.39) | CA1CA2ALOX15EPHX1LMNA | |
| SCHEMBL8312889 | 0.61 | LMNA (0.30) | ALOX15LMNABLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2808329-B1 | Silyl-Protected Nitrogen-Containing Cyclic Compounds and their method of preparation | SHINETSU CHEMICAL CO (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-9745386-B2 | Anti-chondroitin-sulfate-E antibody | SEIKAGAKU CORPORATION (JP) | 2017-08-29 | — | — | US | disclosed |
| US-20170107301-A1 | ANTI-CHONDROITIN-SULFATE-E ANTIBODY | SEIKAGAKU CORPORATION (JP) | 2017-04-20 | — | — | US | disclosed |
| EP-3127922-A1 | ANTI-CHONDROITIN-SULFATE-E ANTIBODY | Seikagaku Corporation (JP) | 2017-02-08 | — | — | EP | disclosed |
| US-9233988-B2 | Silyl-protected nitrogen-containing cyclic compounds and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-01-12 | — | — | US | disclosed |
| EP-2895546-A1 | IMPROVED BONDING COMPOSITION COMPRISING A SULFUR IMPREGNATED PARTICULATE SOLID | Henkel IP & Holding GmbH (DE) | 2015-07-22 | — | — | EP | disclosed |
| EP-2895544-A1 | IMPROVED BONDING COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2015-07-22 | — | — | EP | disclosed |
| US-20140357862-A1 | SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-2808329-A1 | Silyl-Protected Nitrogen-Containing Cyclic Compounds and Making Method | Shin-Etsu Chemical Co., Ltd. (JP) | 2014-12-03 | — | — | EP | disclosed |
| WO-2014040645-A1 | IMPROVED BONDING COMPOSITION COMPRISING A SULFUR IMPREGNATED PARTICULATE SOLID | HENKEL AG & CO. KGAA (DE) | 2014-03-20 | — | — | WO | disclosed |
| EP-0484094-B1 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO CO (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0323427-A2 | Light-sensitive compositions with phenol resins and quinone diarides | U C B, S.A. (BE) | 1989-07-05 | — | — | EP | disclosed |
| EP-0248779-A1 | Process for producing positive patterns in a photoresist layer | U C B, S.A. (BE) | 1987-12-09 | — | — | EP | disclosed |
| EP-0033965-B1 | NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-05-15 | — | — | EP | disclosed |
| US-4460502-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-17 | — | — | US | disclosed |
| US-4385176-A | RING EXPANSION USING A LEWIS ACID | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-05-24 | — | — | US | disclosed |
| EP-0051812-A1 | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-05-19 | — | — | EP | disclosed |
| US-4308380-A | 2-Lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-29 | — | — | US | disclosed |
| US-4113940-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4105648-A | CROSSLINKED POLYACRYLAMIDES CONTAINING SILYL GROUPS | CIBA-GEIGY CORPORATION (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357862-A1 | SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD | PRMT9, CCNO, IPO9 | CA1 668/4885CA2 2436/4885ALOX15 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.